HUP9903779A3 - Method for treating amyotrophic lateral sclerosis - Google Patents

Method for treating amyotrophic lateral sclerosis

Info

Publication number
HUP9903779A3
HUP9903779A3 HU9903779A HUP9903779A HUP9903779A3 HU P9903779 A3 HUP9903779 A3 HU P9903779A3 HU 9903779 A HU9903779 A HU 9903779A HU P9903779 A HUP9903779 A HU P9903779A HU P9903779 A3 HUP9903779 A3 HU P9903779A3
Authority
HU
Hungary
Prior art keywords
lateral sclerosis
amyotrophic lateral
treating amyotrophic
treating
sclerosis
Prior art date
Application number
HU9903779A
Other languages
English (en)
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of HUP9903779A2 publication Critical patent/HUP9903779A2/hu
Publication of HUP9903779A3 publication Critical patent/HUP9903779A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/185—Nerve growth factor [NGF]; Brain derived neurotrophic factor [BDNF]; Ciliary neurotrophic factor [CNTF]; Glial derived neurotrophic factor [GDNF]; Neurotrophins, e.g. NT-3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
HU9903779A 1996-09-13 1997-09-10 Method for treating amyotrophic lateral sclerosis HUP9903779A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9611186A FR2753379B1 (fr) 1996-09-13 1996-09-13 Methode de traitement de la sclerose laterale amyotrophique
PCT/FR1997/001589 WO1998011213A1 (fr) 1996-09-13 1997-09-10 Methode de traitement de la sclerose laterale amyotrophique

Publications (2)

Publication Number Publication Date
HUP9903779A2 HUP9903779A2 (hu) 2000-03-28
HUP9903779A3 true HUP9903779A3 (en) 2002-01-28

Family

ID=9495715

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9903779A HUP9903779A3 (en) 1996-09-13 1997-09-10 Method for treating amyotrophic lateral sclerosis

Country Status (16)

Country Link
US (1) US6723315B1 (hu)
EP (1) EP0929671A1 (hu)
JP (1) JP2001504088A (hu)
KR (1) KR20010029506A (hu)
CN (1) CN1155706C (hu)
AU (1) AU740641B2 (hu)
BR (1) BR9711955A (hu)
CA (1) CA2259283A1 (hu)
CZ (1) CZ84799A3 (hu)
FR (1) FR2753379B1 (hu)
HU (1) HUP9903779A3 (hu)
IL (1) IL128185A0 (hu)
NO (1) NO991158L (hu)
SK (1) SK31899A3 (hu)
WO (1) WO1998011213A1 (hu)
ZA (1) ZA978257B (hu)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ533833A (en) * 2001-12-21 2008-01-31 Salk Inst For Biological Studi Targeted retrograde gene delivery to motor neurons
US20070049630A1 (en) * 2005-08-24 2007-03-01 Allergan, Inc. Method of using ryanodine receptor antagonists to treat amyotrophic lateral sclerosis
JP2011527317A (ja) * 2008-07-11 2011-10-27 グラクソ グループ リミテッド Ｎｏｇｏ−ａアンタゴニストによる筋萎縮性側索硬化症の治療
CA2885216A1 (en) * 2012-09-17 2014-03-20 The Research Institute At Nationwide Children's Hospital Compositions and methods for treating amyotrophic lateral sclerosis
CA2929669A1 (en) 2013-11-05 2015-05-14 The Research Institute At Nationwide Children's Hospital Compositions and methods for inhibiting nf-.kappa.b and sod-1 to treat amyotrophic lateral sclerosis
MX2018011744A (es) * 2016-03-31 2019-05-30 Univ Cincinnati Metodos y composiciones para el tratamiento de esclerosis lateral amiotrofica.
EP3844285A4 (en) * 2018-08-30 2022-06-29 Rowan University Methods of treating or preventing amyotrophic lateral sclerosis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE903130A1 (en) * 1989-09-15 1991-03-27 Regeneron Pharma Ciliary neurotrophic factor
FR2688138B1 (fr) * 1992-03-06 1995-05-05 Rhone Poulenc Rorer Sa Application de l'amino-2 trifluoromethoxy-6 benzothiazole pour obtenir un medicament destine au traitement de la sclerose laterale amyotrophique.
FR2717496B1 (fr) * 1994-03-18 1996-04-12 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
ATE404683T1 (de) * 1992-09-25 2008-08-15 Aventis Pharma Sa Adenovirus vektoren für die übertragung fremder gene in zellen des zentralen nervensystems, insbesondere im gehirn
FR2717824B1 (fr) * 1994-03-25 1996-04-26 Rhone Poulenc Rorer Sa Virus recombinants, préparation et utilisation en thérapie génique.
FR2724945B1 (fr) 1994-09-27 1996-12-27 Centre Nat Rech Scient Vecteurs viraux et utilisation en therapie genique
BR9810500A (pt) 1997-06-30 2000-09-05 Rhone Poulenc Rorer Sa Sistema e aparelho para a transferência de ácido nucléico in vivo para o interior de células de organismos eucarióticos pluricelulares

Also Published As

Publication number Publication date
CN1225131A (zh) 1999-08-04
CN1155706C (zh) 2004-06-30
BR9711955A (pt) 1999-08-24
JP2001504088A (ja) 2001-03-27
AU4212597A (en) 1998-04-02
AU740641B2 (en) 2001-11-08
EP0929671A1 (fr) 1999-07-21
FR2753379A1 (fr) 1998-03-20
CA2259283A1 (fr) 1998-03-19
NO991158D0 (no) 1999-03-10
NO991158L (no) 1999-03-10
ZA978257B (en) 1998-03-24
IL128185A0 (en) 1999-11-30
CZ84799A3 (cs) 1999-06-16
WO1998011213A1 (fr) 1998-03-19
US6723315B1 (en) 2004-04-20
KR20010029506A (ko) 2001-04-06
HUP9903779A2 (hu) 2000-03-28
FR2753379B1 (fr) 1998-10-30
SK31899A3 (en) 1999-10-08

Similar Documents

Publication Publication Date Title
IL126203A0 (en) Method for treating pain
EP0906104A4 (en) PAIN TREATMENT PROCESS
ZA987798B (en) Method for treating chapped lips
EP0896066A4 (en) METHOD AND DEVICE FOR PRODUCING REDUCED IRON
SG50018A1 (en) Method for developing treatment
ZA959167B (en) Method for treating anxiety
IL126759A0 (en) Method for treating inflammation
HK1039449A1 (zh) 治療多發性硬化的方法
IL125031A0 (en) Method for treating depression
IL126064A0 (en) Method for treating pain
EP1009403A4 (en) METHOD FOR TREATING SCHIZOPHRENIA
AU7204996A (en) Method for treating amyotrophic lateral sclerosis
HUP9903779A3 (en) Method for treating amyotrophic lateral sclerosis
EP0956025A4 (en) PROCEDURE FOR IMMUNE SUPPRESSION
EP0769904A4 (en) METHOD FOR TREATING ANXIETIES
ZA971899B (en) Method for treating insomnia
EP0783304A4 (en) METHOD FOR TREATING FEELINGS
GB9517701D0 (en) Method for treating hyperlipidemia
EP1043994A4 (en) METHOD OF TREATING MULTIPLE SCLEROSIS
EP0998253A4 (en) METHOD FOR TREATING CRACKED LIPS
AP9701121A0 (en) Method for prearing streptogramines
IL126160A0 (en) Method for treating insomnia
GB9606616D0 (en) Method for treating autism
IL139506A0 (en) Method for treating autism
GB9602269D0 (en) Novel compounds and methods for treating multiple sclerosis